Literature DB >> 12853442

Effects of 4-aminopyridine on stretched mammalian spinal cord: the role of potassium channels in axonal conduction.

Jennifer M Jensen1, Riyi Shi.   

Abstract

Axonal conduction deficit is a major contributor to various degrees of disability after spinal cord injury. 4-aminopyridine (4-AP), a potassium channel blocker, has been shown to restore some conduction and improve neurological function in both animal and human studies. Using a double sucrose-gap recording device, we have examined the effects of 4-AP on isolated guinea pig spinal cord white matter after stretch injury. At a concentration of 100 microM, 4-AP increased the amplitude of the compound action potential by 100% while 1 microM 4-AP increased it by 43%, a larger response than seen following compression injury. The length of affected tissue is suggested as a potential explanation of this differential sensitivity to 4-AP. Plastic sections taken from the injury site revealed severe myelin damage, especially in the paranodal area, which may also partially explain why 4-AP has more effect on conduction after stretch injury than compression. In addition, we have shown that while enhancing conductivity in some axons, 4-AP significantly reduced the overall responsiveness to multiple stimuli, as evidenced by increase of the refractory period in response to dual stimuli and the decreased ability to follow repetitive stimuli. This increased refractoriness may be largely attributed to residual deficits in fibers newly recruited by 4-AP treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853442     DOI: 10.1152/jn.00868.2002

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  21 in total

1.  The effects of paranodal myelin damage on action potential depend on axonal structure.

Authors:  Ehsan Daneshi Kohan; Behnia Shadab Lashkari; Carolyn Jennifer Sparrey
Journal:  Med Biol Eng Comput       Date:  2017-08-03       Impact factor: 2.602

Review 2.  Molecular mechanisms of acrolein-mediated myelin destruction in CNS trauma and disease.

Authors:  R Shi; J C Page; M Tully
Journal:  Free Radic Res       Date:  2015-04-16

3.  Potassium channel blocker, 4-aminopyridine-3-methanol, restores axonal conduction in spinal cord of an animal model of multiple sclerosis.

Authors:  Gary Leung; Wenjing Sun; Sarah Brookes; Daniel Smith; Riyi Shi
Journal:  Exp Neurol       Date:  2010-11-17       Impact factor: 5.330

Review 4.  Potassium channel blockers as an effective treatment to restore impulse conduction in injured axons.

Authors:  Riyi Shi; Wenjing Sun
Journal:  Neurosci Bull       Date:  2011-02       Impact factor: 5.203

Review 5.  Acrolein-mediated injury in nervous system trauma and diseases.

Authors:  Riyi Shi; Todd Rickett; Wenjing Sun
Journal:  Mol Nutr Food Res       Date:  2011-08-08       Impact factor: 5.914

Review 6.  Mechanisms of neuronal membrane sealing following mechanical trauma.

Authors:  Benjamin K Hendricks; Riyi Shi
Journal:  Neurosci Bull       Date:  2014-07-04       Impact factor: 5.203

7.  Paranodal myelin damage after acute stretch in Guinea pig spinal cord.

Authors:  Wenjing Sun; Yan Fu; Yuzhou Shi; Ji-Xin Cheng; Peng Cao; Riyi Shi
Journal:  J Neurotrauma       Date:  2011-12-05       Impact factor: 5.269

8.  Facile fabrication of flexible glutamate biosensor using direct writing of platinum nanoparticle-based nanocomposite ink.

Authors:  Tran N H Nguyen; James K Nolan; Hyunsu Park; Stephanie Lam; Mara Fattah; Jessica C Page; Hang-Eun Joe; Martin B G Jun; Hyungwoo Lee; Sang Joon Kim; Riyi Shi; Hyowon Lee
Journal:  Biosens Bioelectron       Date:  2019-01-31       Impact factor: 10.618

Review 9.  4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review.

Authors:  Henrik Boye Jensen; Mads Ravnborg; Ulrik Dalgas; Egon Stenager
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

10.  Glutamate excitotoxicity inflicts paranodal myelin splitting and retraction.

Authors:  Yan Fu; Wenjing Sun; Yunzhou Shi; Riyi Shi; Ji-Xin Cheng
Journal:  PLoS One       Date:  2009-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.